These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 17364448

  • 1. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
    Hermann M, Ruschitzka F.
    Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 inhibitors and cardiovascular risk.
    Solomon SD.
    Curr Opin Cardiol; 2006 Nov; 21(6):613-7. PubMed ID: 17053413
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S.
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [Abstract] [Full Text] [Related]

  • 6. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs].
    Lange H, Eberhart L.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
    Woodruff T.
    Intern Med J; 2006 Dec; 36(12):797-8; author reply 798-9. PubMed ID: 17096747
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
    Fosslien E.
    Ann Clin Lab Sci; 2005 Dec; 35(4):347-85. PubMed ID: 16254252
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs.
    Maillard M, Burnier M.
    Expert Opin Drug Saf; 2006 Jan; 5(1):83-94. PubMed ID: 16370958
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [Abstract] [Full Text] [Related]

  • 16. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
    Hinz B, Renner B, Brune K.
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
    [Abstract] [Full Text] [Related]

  • 17. The murky waters of the coxibs: a review of the current state of play.
    Ostor AJ, Hazleman BL.
    Inflammopharmacology; 2005 Oct; 13(4):371-80. PubMed ID: 16354390
    [Abstract] [Full Text] [Related]

  • 18. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Farkouh ME, Greenberg BP.
    Am J Cardiol; 2009 May 01; 103(9):1227-37. PubMed ID: 19406264
    [Abstract] [Full Text] [Related]

  • 19. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
    van den Bemt BJ, Benraad HB, Rasker JJ.
    Ned Tijdschr Geneeskd; 2007 May 12; 151(19):1062-7. PubMed ID: 17552414
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals.
    Fosbøl EL, Køber L, Torp-Pedersen C, Gislason GH.
    Expert Opin Drug Saf; 2010 Nov 12; 9(6):893-903. PubMed ID: 20569079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.